3 August company Tivic Health Systems, commercializing a bioelectronic device for the treatment of nasal and sinus inflammation, filed an application with the Securities and Exchange Commission to raise up to 16 million dollars.
Tivic is a commercial bioelectronic device company, specialized in inflammatory diseases. The first product of the company - , is a patented portable device, which uses ultra-low electrical waves to relieve the symptoms of nasal and sinus inflammation. ClearUP is an FDA Class II medical device and an EU Class IIa medical device, obtained three permits for use. The company is currently working on a second generation version of ClearUP. (ClearUP Gen 2), which are covered by the same patents.
Company headquartered in Newark, California, was founded in 2016 year, and for 12 Months, ended 31 Martha 2021 of the year, its sales were 1 million dollars. The company plans to list under the ticker TVC, but haven't chosen the exchange yet.
Tivic Health Systems Filed a Confidential Application 14 May 2021 of the year. The only organizer of the issue of shares was ThinkEquity. Terms of the upcoming IPO are not disclosed.
